The proband’s mother, a 45-year-old, visited the Cancer Hospital of the Chinese Academy of Medical Sciences on February 17, 2023, for tumor genetic susceptibility gene testing: a heterozygous pathogenic mutation in exon 12 c.1921C>T (p.G1n641 *) of CDH1 was detected. This evidence concerns the gene CDH1 and neoplasm.